205.5632 Prior authorization requirements -- Administrative regulations.
167 words·~1 min read·
/ky/chapter-205/205-5632A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(1)Upon initial coverage by the Kentucky Medicaid program, a new drug shall be
exempt from prior authorization unless:
(a)There has been a review of the drug and recommendation regarding prior
authorization by the Pharmacy and Therapeutics Advisory Committee as
provided under KRS 205.564 and a final determination regarding prior
authorization by the secretary of the Cabinet for Health and Family Services;
or
(b)The drug is in a specific class of drugs for which the Pharmacy and
Therapeutics Advisory Committee has recommended, and the secretary of
health and family services has determined, that all new drugs shall require
prior authorization upon initial availability, in which case the drug shall
require prior authorization and shall be scheduled for review by the Pharmacy
and Therapeutics Advisory Committee within seventy-five
(75)days.
(2)The Cabinet for Health and Family Services shall promulgate an administrative
regulation in accordance with KRS Chapter 13A that describes the process by
which drugs under this section shall be determined to require prior authorization.